Expertise in
1
conditions

Josee Brossard

Sherbrooke, QC, CA 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
1
conditions
Sherbrooke, QC, CA 

Overview

Josee Brossard practices practicing medicine in Sherbrooke, Canada.

Ms. Brossard is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Medulloblastoma, Pure Red Cell Aplasia, Infantile Neutropenia, and Aase Syndrome.

She is actively involved in clinical research, co-authoring 36 peer reviewed articles and participating in 2 clinical trials.

Gender

Female

Locations

Sherbrooke, QC, Canada
Other Locations
Kingston, ON, Canada
Montreal, QC, Canada
CHU de Sherbrooke, Univesité de Sherbrooke, Québec
Sherbrooke, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 3 Randomized Trial of Inotuzumab Ozogamicin (IND#:133494, NSC#: 772518) for Newly Diagnosed High-Risk B-ALL; Risk-Adapted Post-Induction Therapy for High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and Disseminated B-LLy
A Phase 3 Randomized Trial of Inotuzumab Ozogamicin (IND#:133494, NSC#: 772518) for Newly Diagnosed High-Risk B-ALL; Risk-Adapted Post-Induction Therapy for High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and Disseminated B-LLy
Enrollment Status: Recruiting
Publish Date: June 18, 2026
Intervention Type: Procedure, Drug, Biological, Radiation, Other
Study Drugs: Calaspargase, Cyclophosphamide, Cytarabine, Daunorubicin, Dexamethasone, Doxorubicin, Inotuzumab, Leucovorin, 6-Mercaptopurine, Methotrexate, Pegaspargase, Prednisolone, Thioguanine, Vincristine
Study Phase: Phase 3
A Phase 3 Trial Investigating Blinatumomab (NSC# 765986) in Combination With Chemotherapy in Patients With Newly Diagnosed Standard Risk or Down Syndrome B-Lymphoblastic Leukemia (B-ALL) and the Treatment of Patients With Localized B-Lymphoblastic Lymphoma (B-LLy)
A Phase 3 Trial Investigating Blinatumomab (NSC# 765986) in Combination With Chemotherapy in Patients With Newly Diagnosed Standard Risk or Down Syndrome B-Lymphoblastic Leukemia (B-ALL) and the Treatment of Patients With Localized B-Lymphoblastic Lymphoma (B-LLy)
Enrollment Status: Active_not_recruiting
Publish Date: June 17, 2026
Intervention Type: Drug, Biological, Radiation
Study Drugs: Erwinia Asparaginase, Blinatumomab, Cyclophosphamide, Cytarabine, Dexamethasone, Doxorubicin Hydrochloride, Leucovorin Calcium, Mercaptopurine, Methotrexate, Pegaspargase, Prednisolone, Prednisone, Thioguanine, Vincristine Sulfate
Study Phase: Phase 3
View 1 Less Clinical Trial

36 Total Publications

Outcomes of Dyskeratosis Congenita: Results From the Canadian Inherited Marrow Failure Registry.
Outcomes of Dyskeratosis Congenita: Results From the Canadian Inherited Marrow Failure Registry.
Journal: Journal of pediatric hematology/oncology
Published: October 28, 2025

Frequently Asked Questions about Josee Brossard

Is Josee Brossard a top-rated expert for Medulloblastoma?

MediFind is an objective health platform that identifies experts based on real-world data. Josee Brossard is classified as an Advanced expert for Medulloblastoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Josee Brossard participate in research or clinical trials?

Yes. Josee Brossard has published 36 articles and abstracts on conditions like Medulloblastoma. You can view a list of Josee Brossard's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Brossard's expertise for a condition
ConditionClose
      View All 25 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile